Navigation Links
MedServe to be Acquired by Stericycle for $185 Million
Date:5/14/2009

HOUSTON, May 14 /PRNewswire/ -- MedServe, Inc., a private company, today announced that it has entered into an agreement to be acquired by Stericycle, Inc. (Nasdaq: SRCL) for $185 million in cash.

MedServe has been majority-owned by Avista Capital Partners, Chrysalis Ventures and Murphree Venture Partners since September 2006. MedServe is engaged in the collection, transportation, treatment and disposal of medical waste, hazardous waste, universal waste and other regulated wastes; sharps management services; safety and compliance training services; and other related businesses.

Roger Ramsey, Chairman and Chief Executive Officer of MedServe, said, "We would like to thank Avista, Chrysalis, Murphree and our other shareholders for their commitment to MedServe over the last three years. We are grateful for their support of the company's strategic vision and assistance in achieving this successful event.

"Most importantly, I would like to express my appreciation for MedServe's talented, dedicated and experienced employees. It is through their hard work that our company has experienced such rapid growth in the U.S."

Steve Webster, Co-Managing Partner of Avista, said, "MedServe has made significant progress during the period of Avista, Chrysalis and Murphree's ownership. The company has grown into a great business with an exceptional base of employees. The entire investor group is delighted to have sponsored MedServe and that we were able to partner with the company's outstanding management team."

The transaction is subject to customary closing conditions and regulatory reviews, including clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.

About MedServe

MedServe, Inc., headquartered in Houston, Texas, is engaged in the collection, transportation, treatment and disposal of medical waste, hazardous waste, universal waste and other regulated wastes; sharps management services; safety and compliance training services; and other related businesses. For additional information about MedServe, please visit www.medserve.com.

About Avista Capital Partners

Founded in 2005, Avista Capital Partners is a leading private equity firm with offices in New York, NY and Houston, TX. Avista's strategy is to make controlling or influential minority investments primarily in growth-oriented energy, healthcare and media companies. Through its team of seasoned investment professionals and industry experts, Avista seeks to partner with exceptional management teams to invest in and add value to well-positioned businesses. For more information, visit www.avistacap.com.

About Chrysalis Ventures

Founded in 1993, Chrysalis Ventures is the premier venture capital firm in Mid-America, managing one of the region's largest funds for early-stage and growth investments. Chrysalis invests primarily in early-stage and expansion-stage companies in healthcare services and technology, media and communications, and emerging trends and technologies. Based in Louisville, Kentucky, Chrysalis has approximately $400 million under management and has made investments in 60 companies. For more information, visit www.chrysalisventures.com.

About Murphree Venture Partners

Murphree Venture Partners is a venture capital/private equity firm that makes investments in entrepreneurial enterprises with high-growth potential. Murphree seeks to align itself with entrepreneurs and management groups with whom it can develop strong working relationships, and with whom it can act in concert as owners/investors. Murphree invests in the Sun Belt region of the U.S. from its four offices in Houston, Austin, Baton Rouge and Birmingham. For more information, visit www.murphco.com.

    Media Contact
    Diana Postemsky, Kekst and Company, 212-521-4805


'/>"/>
SOURCE MedServe, Inc.; Avista Capital Partners
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Meritain Health Announces Name Change for Acquired Companies
2. Aspreva to be Acquired by Galenica For US$915 Million
3. Alarming MRSA Infection Rates Underscore Need for Public Reporting of Hospital-Acquired Infections
4. Key Cleaning Solutions Products Utilized to Combat Community Acquired - MRSA (CA-MRSA) Are Succeeding In Killing Superbugs Where Normal Cleaning Practices and Products Are Not
5. Microflex(R) Corporation Acquired by Linden and Edgewater
6. MicroActive Corporation Acquired by Linden and Edgewater
7. Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS)
8. Study Showed Minimally Invasive Surgery Reduced Risk of Hospital-Acquired Infections Compared to Open Surgery
9. Bayer/Schering-Plough/Shionogis Avelox Has Advantages Over Levofloxacin in the Treatment of Community-Acquired Pneumonia
10. HTG-Ventrex, Signalifes Contract Manufacturer, Acquired by Parker Hannifin Corporation
11. Gender disparity in community-acquired pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: